Fundacao Butantan
SP Pesquisa
- UEI
- NCNFP5KBNNH6
- CAGE
- 01J5K
- Primary NAICS
- 813212 Voluntary Health Organizations
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Country - Foreign Government
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- Av. Vital Brasil, 1500 - Butantã, São Paulo - SP, 05581, Brazil
- Website
- fundacaobutantan.org.br
- Founded
- 1989
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $103,683 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase of 300 equine anti diphtheria toxin 10ML vials. | CDC Pittsburgh | $103,683 | |
| Anti diphitheria toxin kits | CDC Pittsburgh | $24,568 | |
| Anti diphitheria toxin 10ML | CDC Pittsburgh | $9,867 | |
| Toxin for anti diphitheria | CDC Pittsburgh | $7,415 |
Similar vendors
About the company
Fundacao Butantan is a prominent Brazilian foundation located in São Paulo, primarily known as a leading producer of immunobiologicals in Brazil. As a foreign government entity registered in SAM.gov since July 2010, the organization has established itself as a critical supplier of specialized medical and biological products to U.S. federal agencies. The Pesquisa Division of Fundacao Butantan focuses on research and production of specialized medical toxins and biological products, with a particular emphasis on anti-diphtheria treatments and related medical interventions.
The organization has consistently engaged with the Centers for Disease Control and Prevention (CDC) Pittsburgh office through multiple federal contract awards, specifically providing anti-diphtheria toxin products. These contracts have ranged from $9,867 to $103,682.62, with purchase orders for equine anti-diphtheria toxin vials and anti-diphtheria toxin kits. The contracts have been standard purchase orders without any specific set-aside designations, indicating direct procurement based on the organization's specialized capabilities. Each contract has had a defined completion date, with the most recent award dated August 22, 2025, for 300 equine anti-diphtheria toxin 10ML vials, demonstrating the organization's ongoing role in supplying critical medical biological products to U.S. federal health agencies. The consistent nature of these awards suggests Fundacao Butantan has developed a reliable reputation for producing high-quality, specialized medical toxin products needed by U.S. public health institutions.
Quick answers
Is Fundacao Butantan registered in SAM.gov?
Yes. Fundacao Butantan's SAM.gov registration is active through May 15, 2027.
How much has Fundacao Butantan received in federal contracts?
Federal contracts obligated $103,683 to Fundacao Butantan in fiscal year 2025.
How does Fundacao Butantan rank among federal contractors?
Fundacao Butantan ranked #59 in NAICS 325414 in FY2025.
What is Fundacao Butantan's most recent federal award?
Fundacao Butantan's most recent federal contract award is Purchase of 300 equine anti diphtheria toxin 10ML vials (75D30125P00256), from CDC Pittsburgh, on August 22, 2025.
On GovTribe
See Fundacao Butantan's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors